Today, Ohioans on Medicare are saving money on insulin every single month. And we are fighting to extend those cost savings to everyone.

After years of fighting against Big Pharma lobbyists and the politicians who do their bidding, we took major steps in 2022 to lower the cost of insulin and other prescription drugs.

For people with diabetes, insulin is a necessity. It costs less than $10 to make one vial, yet Big Pharma has made it one of the most overpriced drugs out there because they know that patients have no choice but to pay.

We used to organize bus trips to Canada so that seniors could purchase their medications at a fair price. Now, when it comes to insulin, Ohioans on Medicare can pay fair prices from home.

Thanks to our work to cap out-of-pocket insulin costs at $35 per month for people on Medicare, tens of thousands of Ohioans are now saving hundreds of dollars each year.

We can’t stop there. I’m fighting to extend the insulin price cap for all Ohioans, not just those on Medicare. Anyone who needs insulin should not pay more than $35 out-of-pocket each month.

For too long, Big Pharma’s gotten away with price gouging Ohioans across our state. I’ll always stand on the side of Ohioans, and I’ll always stand up to Big Pharma.

• Sherrod raised the alarm about a new report that details alarming ties between Nippon Steel and the Chinese steel industry — one of many reasons U.S. Steel should not be sold to Nippon.
• New federal rules require all large freight trains to have at least two people onboard at all times. This is a good first step, but Congress still needs to pass Sherrod’s bipartisan Railway Safety Act, which would make these rules permanent and require better safety inspections to prevent future train derailments.